GlassScriptPhysician profile
Julia L Ponder
NPI 1144740796
$20,777.58
in general payments reported to CMS, 2019-2025
15 companies · $2,966 in 2025
The $2,966 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $9,696 · 2022: $1,528 · 2023: $3,435 · 2024: $3,153 · 2025: $2,966.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,100 · Travel and Lodging: $776 · Food and Beverage: $678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,100.00 |
| Travel and Lodging | $775.55 |
| Food and Beverage | $678.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $19,233.13 | 2021-2025 | Lokelma |
| Amgen INC. | $228.59 | 2023-2025 | Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $174.46 | 2021 | |
| Scynexis, INC. | $140.15 | 2022 | |
| Janssen Pharmaceuticals, INC | $138.74 | 2021-2022 | |
| Horizon Therapeutics Plc | $123.42 | 2021 | |
| Novo Nordisk INC | $122.13 | 2022 | |
| Corcept Therapeutics | $111.09 | 2025 | Korlym |
| Alnylam Pharmaceuticals INC. | $101.39 | 2022 | |
| Avanir Pharmaceuticals, INC. | $100.44 | 2021 | |
| Lilly USA, LLC | $89.28 | 2025 | Zepbound |
| Abbvie INC. | $73.20 | 2022 | |
| Grifols USA, LLC | $72.75 | 2022 | |
| Pfizer INC. | $34.81 | 2021 | |
| Neurocrine Biosciences, INC. | $34.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Ponder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.